Direct Interactions with the Integrin β1 Cytoplasmic Tail Activate the Abl2/Arg Kinase

被引:33
|
作者
Simpson, Mark A. [1 ]
Bradley, William D. [1 ]
Harburger, David [2 ]
Parsons, Maddy [5 ]
Calderwood, David A. [2 ,3 ]
Koleske, Anthony J. [1 ,4 ]
机构
[1] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA
[2] Yale Univ, Dept Pharmacol, New Haven, CT 06510 USA
[3] Yale Univ, Dept Cell Biol, New Haven, CT 06510 USA
[4] Yale Univ, Dept Neurobiol, New Haven, CT 06510 USA
[5] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England
基金
美国国家卫生研究院;
关键词
ABL TYROSINE KINASE; CELL EDGE PROTRUSION; C-ABL; FAMILY KINASES; SIGNAL-TRANSDUCTION; STRUCTURAL BASIS; N-WASP; ARG; PHOSPHORYLATION; ADHESION;
D O I
10.1074/jbc.M115.638874
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Integrins are heterodimeric alpha/beta extracellular matrix adhesion receptors that couple physically to the actin cytoskeleton and regulate kinase signaling pathways to control cytoskeletal remodeling and adhesion complex formation and disassembly. beta 1 integrins signal through the Abl2/Arg ( Abl-related gene) nonreceptor tyrosine kinase to control fibroblast cell motility, neuronal dendrite morphogenesis and stability, and cancer cell invasiveness, but the molecular mechanisms by which integrin beta 1 activates Arg are unknown. We report here that the Arg kinase domain interacts directly with a lysine-rich membraneproximal segment in the integrin beta 1 cytoplasmic tail, that Arg phosphorylates the membrane-proximal Tyr-783 in the beta 1 tail, and that the Arg Src homology domain then engages this phosphorylated region in the tail. We show that these interactions mediate direct binding between integrin beta 1 and Arg in vitro and in cells and activate Arg kinase activity. These findings provide a model for understanding how beta 1-containing integrins interact with and activate Abl family kinases.
引用
收藏
页码:8360 / 8372
页数:13
相关论文
共 50 条
  • [41] The Tyrosine Kinases Abl1 And Abl2 Have Distinct Roles In Inflammatory Vascular Leak
    Aman, J.
    Van Bezu, J.
    Eringa, E.
    Van Hinsbergh, V. W. M.
    Amerongen, G. P. Van Nieuw
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [42] Src kinase activation by a novel and direct interaction with the integrin β cytoplasmic domain.
    Arias-Salgado, EG
    Lizano, S
    Sarkar, S
    Brugge, JS
    Ginsberg, MH
    Shattil, SJ
    BLOOD, 2003, 102 (11) : 50A - 50A
  • [43] Abl2 is recruited to ventral actin waves through cytoskeletal interactions to promote lamellipodium extension
    Zhang, Ke
    Lyu, Wanqing
    Yu, Ji
    Koleske, Anthony J.
    MOLECULAR BIOLOGY OF THE CELL, 2018, 29 (23) : 2863 - 2873
  • [45] Ligand-binding activity of α7 integrin is regulated by β1 cytoplasmic tail
    Yeh, MG
    Ziober, BL
    Kramer, RH
    MOLECULAR BIOLOGY OF THE CELL, 1998, 9 : 416A - 416A
  • [46] NPXY motifs in the β1 integrin cytoplasmic tail are required for functional reovirus entry
    Maginnis, Melissa S.
    Mainou, Bernardo A.
    Derdowski, Aaron
    Johnson, Elizabeth M.
    Zent, Roy
    Dermody, Terence S.
    JOURNAL OF VIROLOGY, 2008, 82 (07) : 3181 - 3191
  • [47] RETRACTED: One isoform of Arg/Abl2 tyrosine kinase is nuclear and the other seven cytosolic isoforms differently modulate cell morphology, motility and the cytoskeleton (Retracted Article)
    Bianchi, Cristina
    Torsello, Barbara
    Di Stefano, Vitalba
    Zipeto, Maria A.
    Facchetti, Rita
    Bombelli, Silvia
    Perego, Roberto A.
    EXPERIMENTAL CELL RESEARCH, 2013, 319 (13) : 2091 - 2102
  • [48] Structural insights into the recognition of β3 integrin cytoplasmic tail by the SH3 domain of Src kinase
    Katyal, Priya
    Puthenveetil, Robbins
    Vinogradova, Olga
    PROTEIN SCIENCE, 2013, 22 (10) : 1358 - 1365
  • [49] Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor
    Yu, HH
    Zisch, AH
    Dodelet, VC
    Pasquale, EB
    ONCOGENE, 2001, 20 (30) : 3995 - 4006
  • [50] Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy
    Eadie, Laura N.
    Lagonik, Elias
    Page, Elyse C.
    Schutz, Caitlin E.
    Heatley, Susan L.
    McClure, Barbara J.
    Forgione, Michelle O.
    Yeung, David T.
    Hughes, Timothy P.
    White, Deborah L.
    BLOOD, 2024, 144 (09) : 1022 - 1026